Humanin
ResearchHumanin (HN)
- Category
- Longevity & Anti-Aging
- Aliases
- Mitochondrial-derived peptide (MDP)
- Administration
- Subcutaneous injection (research)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Effects are generally described as subtle, if present, given the compound's cellular-level mechanism.
- 2
3–4 Weeks
No consistent early felt pattern has been established in available research.
- 3
5–7 Weeks
Limited human trial data makes a felt timeline difficult to characterize at this stage.
- 4
8–10 Weeks
Available evidence does not describe a distinct sensation at this duration.
- 5
11–15 Weeks
Continued use is generally evaluated through biomarkers rather than felt sensation.
- 6
16–20 Weeks
No established human timeline exists to reference at this stage.
- 7
21–24 Weeks
By this point, any felt-effect assessment would be based on limited available evidence.
⚠️ Research context only. This is not medical advice and results are not guaranteed.